Coagulation Analyzer Market Development And Business Intelligence
Summary
- Major factors influencing the growth of the market.
- Leading players & Top Segments.
- Geographic Overview.
Market growth influenced due to following factors-
- Increasing prevalence of cardiovascular diseases and blood disorders.
- Technological advancements in coagulation analyzers.
- Rising geriatric population.
- Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years.
Global market size-
According to market research report the Coagulation Analyzer Market is projected to reach $5.0 billion by 2025, at a CAGR of 5.7% between 2020 and 2025.
Leading Players-
Siemens Healthineers (Germany), Thermo Fisher Scientific (US), Roche Diagnostics (Switzerland), Alere, Inc. (US), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (US), and Horiba Medical (Japan) are some of the key players operating in this Coagulation Analyzer Market.
Top Market Segments-
Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. In 2019, the clinical laboratory analyzers segment accounted for a larger share of the market.
The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology. However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies. The most widely used technology in the Hemostasis Analyzer Market is the optical technology. This segment accounted for the largest share of the market in 2019.
For Details, Download PDF Brochure
Geographic Overview -
North America (comprising the US and Canada) accounted for the largest share of the global Coagulation Analyzer Market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the market in North America.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.